HIGHLIGHTS
- What: This work showed promising results, so other clinical trials using similar methods targeting NSCLCs and head and neck cancers (HNCs) were conducted at the facility .
- Who: Luc Van Kaer et al. from the Vanderbilt University Medical Center, United States have published the research: Comparative assessment of autologous and allogeneic iNKT cell transfer in iNKT cell-based immunotherapy, in the Journal: (JOURNAL)
- How: The results indicated that the infusion of iNKT_cells significantly improved progression-free survival overall response rate disease control and quality of life while keeping toxicity at manageable levels.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.